Travoprost Intraocular Implant + iStent Infinite
Glaukos Corporation · NCT06066645
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 18+ · All sexes
- Healthy volunteers
- Not accepted (a condition is required)
- Study type
- Interventional · Phase 4
- Target enrollment
- 150
- US sites recruiting
- 1
- Study start
- September 14, 2023
- Record last updated
- June 2, 2026
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
Adult subjects with elevated intraocular pressure will be randomized to receive iStent infinite trabecular bypass system plus a travoprost intraocular implant or receive a sham procedure plus a travoprost intraocular implant and be followed for 12 months.
Being studied: Travoprost Intraocular Implant; iStent infinite; Sham procedure
Conditions: Glaucoma, Open-Angle
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- diagnosis of open-angle glaucoma or ocular hypertension
- qualifying IOP in the study eye
Exclusion Criteria
- unmedicated (washed out) IOP of >36 mmHg in the study eye
- hypersensitivity to travoprost or any other components of the travoprost intraocular implant
- vertical cup/disc ratio > 0.8 in the study eye
- best spectacle corrected visual acuity of worse than 20/80 in either eye
- any ocular disease or condition that, in the opinion of the investigator, may put the subject at significant risk, may confound the study results, or may interfere significantly with the subject's participation in the study
Recruiting US locations
Glaukos Clinical Study Site
Oklahoma City, OK 73112
Site contact: Study Director · 949-739-8749 · idoseclinical@Glaukos.com
Study contacts (from the official record)
- Study Director · 949-739-8749 · idoseclinical@glaukos.com
- Study Manager · 949-739-8749 · idoseclinical@glaukos.com